Table 2 Number of patients with each symptom at baseline
|  | Omeprazole group (n = 139) | Famotidine group (n = 129) | Mosapride group (n = 118) | Teprenone group (n = 68) | ||||
|---|---|---|---|---|---|---|---|---|
Stomach pain | 87 | (14.6) | 90 | (17.5) | 74 | (15.2) | 51 | (16.1) |
Heartburn | 89 | (15.0) | 75 | (14.6) | 64 | (13.1) | 43 | (13.6) |
Regurgitation | 66 | (11.1) | 54 | (10.5) | 60 | (12.3) | 35 | (11.1) |
Postprandial fullness | 113 | (19.0) | 100 | (19.5) | 87 | (17.9) | 55 | (17.4) |
Vomiting | 59 | (9.9) | 51 | (9.9) | 54 | (11.1) | 29 | (9.2) |
Belching | 46 | (7.7) | 31 | (6.0) | 34 | (7.0) | 30 | (9.5) |
Early satiety | 60 | (10.1) | 47 | (9.2) | 51 | (10.5) | 33 | (10.4) |
Bloating | 75 | (12.6) | 65 | (12.7) | 63 | (12.9) | 40 | (12.7) |